(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 4.4% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.54%.
Thermo Fisher Scientific's revenue in 2025 is $42,898,000,000.On average, 9 Wall Street analysts forecast TMO's revenue for 2025 to be $16,498,651,524,443, with the lowest TMO revenue forecast at $16,368,929,139,029, and the highest TMO revenue forecast at $16,587,459,987,192. On average, 9 Wall Street analysts forecast TMO's revenue for 2026 to be $17,514,740,940,050, with the lowest TMO revenue forecast at $16,990,885,843,477, and the highest TMO revenue forecast at $18,030,996,706,680.
In 2027, TMO is forecast to generate $18,972,071,287,082 in revenue, with the lowest revenue forecast at $18,571,605,738,055 and the highest revenue forecast at $19,280,501,555,400.